Bifogade filer
Revenio Group’s change negotiations have been concluded
Kurs
-1,77%
Likviditet
0,26 MEUR
Prenumeration
Kalender
| Est. tid* | ||
| 2026-10-29 | 08:00 | Kvartalsrapport 2026-Q3 |
| 2026-08-06 | 08:00 | Kvartalsrapport 2026-Q2 |
| 2026-04-28 | 08:00 | Kvartalsrapport 2026-Q1 |
| 2026-04-15 | N/A | Årsstämma |
| 2026-02-11 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-30 | - | Kvartalsrapport 2025-Q3 |
| 2025-08-07 | - | Kvartalsrapport 2025-Q2 |
| 2025-04-29 | - | Kvartalsrapport 2025-Q1 |
| 2025-04-11 | - | X-dag ordinarie utdelning REG1V 0.40 EUR |
| 2025-04-10 | - | Årsstämma |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-08 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-04-05 | - | X-dag ordinarie utdelning REG1V 0.38 EUR |
| 2024-04-04 | - | Årsstämma |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-10 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-24 | - | X-dag ordinarie utdelning REG1V 0.36 EUR |
| 2023-03-23 | - | Årsstämma |
| 2023-02-09 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-04 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-11 | - | X-dag ordinarie utdelning REG1V 0.34 EUR |
| 2022-04-08 | - | Årsstämma |
| 2022-02-10 | - | Bokslutskommuniké 2021 |
| 2021-10-21 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-05 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-23 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-18 | - | X-dag ordinarie utdelning REG1V 0.32 EUR |
| 2021-03-17 | - | Årsstämma |
| 2021-02-11 | - | Bokslutskommuniké 2020 |
| 2020-10-22 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-06 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-09 | - | X-dag ordinarie utdelning REG1V 0.30 EUR |
| 2020-06-08 | - | Årsstämma |
| 2020-04-22 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-15 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-16 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-21 | - | X-dag ordinarie utdelning REG1V 0.28 EUR |
| 2019-03-20 | - | Årsstämma |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-10-25 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-06 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-20 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-21 | - | X-dag ordinarie utdelning REG1V 0.78 EUR |
| 2018-03-20 | - | Årsstämma |
| 2018-02-15 | - | Bokslutskommuniké 2017 |
| 2017-10-26 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-07 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-22 | - | Årsstämma |
| 2017-04-20 | - | Kvartalsrapport 2017-Q1 |
| 2017-03-23 | - | X-dag ordinarie utdelning REG1V 0.74 EUR |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-10-31 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-08 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-25 | - | Kvartalsrapport 2016-Q1 |
| 2016-03-16 | - | X-dag ordinarie utdelning REG1V 0.70 EUR |
| 2016-03-15 | - | Årsstämma |
| 2016-02-15 | - | Bokslutskommuniké 2015 |
| 2015-10-27 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-10 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-24 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-20 | - | X-dag ordinarie utdelning REG1V 0.45 EUR |
| 2015-03-19 | - | Årsstämma |
| 2015-02-12 | - | Bokslutskommuniké 2014 |
| 2014-10-21 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-04 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-24 | - | Kvartalsrapport 2014-Q1 |
| 2014-03-21 | - | X-dag ordinarie utdelning REG1V 0.30 EUR |
| 2014-03-20 | - | Årsstämma |
| 2014-02-12 | - | Bokslutskommuniké 2013 |
| 2013-12-11 | - | X-dag bonusutdelning REG1V 0.3 |
| 2013-12-09 | - | Extra Bolagsstämma 2013 |
| 2013-10-22 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-28 | - | Kapitalmarknadsdag 2013 |
| 2013-08-05 | - | Kvartalsrapport 2013-Q2 |
| 2013-08-02 | - | X-dag bonusutdelning REG1V 0.12 |
| 2013-04-19 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-28 | - | Split REG1V 10:1 |
| 2013-03-22 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
| 2013-03-21 | - | Årsstämma |
| 2013-02-08 | - | Bokslutskommuniké 2012 |
| 2012-10-19 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-06 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-19 | - | Kvartalsrapport 2012-Q1 |
| 2012-03-29 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
| 2012-03-28 | - | Årsstämma |
| 2012-02-16 | - | Bokslutskommuniké 2011 |
| 2011-10-26 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-08 | - | Kvartalsrapport 2011-Q2 |
| 2011-04-27 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-01 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
| 2011-03-31 | - | Årsstämma |
| 2011-02-16 | - | Bokslutskommuniké 2010 |
| 2010-04-09 | - | X-dag ordinarie utdelning REG1V 0.01 EUR |
| 2009-04-16 | - | X-dag ordinarie utdelning REG1V 0.02 EUR |
| 2008-04-03 | - | X-dag ordinarie utdelning REG1V 0.04 EUR |
| 2007-04-09 | - | X-dag ordinarie utdelning REG1V 0.01 EUR |
| 2006-03-31 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
| 2005-04-01 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
| 2004-03-29 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
| 2003-03-24 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
| 2002-04-15 | - | X-dag ordinarie utdelning REG1V 0.00 EUR |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Mid Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Revenio Group Corporation | Press Release | November 18, 2025 at 11:30:00 EET
In September, Revenio Group initiated change negotiations with its Finnish employees.
The concluded negotiations were conducted in a good and constructive spirit between the employer and the employees’ representative.
Following the negotiations, Revenio Group has decided to adopt a Product Operating Model (POM) designed to further enhance the company’s customer centricity and agility. In the Product Operating Model, customer value and business development drive activities. According to the model, teams, processes and systems are organized around the products. The model also supports the principles of continuous and agile development in product development and product management.
"It is important for us to apply the principle of continuous improvement in everything we do. We also want to ensure that our organization supports the success of both individuals and teams – the key to our sustainable and profitable growth. Our change program is built together with our employees. We are now taking a controlled and long-term approach to preparing the implementation of the product operating model together with our employees," says CEO Jouni Toijala.
The personnel impacts of the concluded negotiations were minor. The change negotiations or the organizational restructuring will not affect Revenio’s financial guidance for the current year.
Further information
CEO Jouni Toijala, tel. +358 50 484 0085
jouni.toijala@revenio.fi
Distribution
Main media
www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand.
In 2024, the Group’s net sales totaled EUR 103.5 million, with an operating profit of EUR 25.0 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.